1-2 of 2
Jorge Enrique E Romaguera, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Prognostic Value of Interim PET Scan in Patients with Classical Hodgkin Lymphoma

Yasuhiro Oki, MD, Hubert Chuang, MD, Beth Chasen, MD, Tinsu Pan, PhD, Michelle A. Fanale, MD, Bouthaina S. Dabaja, MD, Nathan H Fowler, MD, Jorge Enrique E Romaguera, MD, Luis E Fayad, MD, Fredrick B Hagemeister, MD, Alma Rodriguez, Sattva S. Neelapu, MD, Felipe Samaniego, MD, MPH, Larry W Kwak, MD, PhD, Anas Younes, MD
Journal: Blood
Blood (2012) 120 (21): 1529.
https://doi.org/10.1182/blood.V120.21.1529.1529
Published: 2012
Journal Articles

Interim Results of an International, Multicenter, Phase 2 Study of Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib (PCI-32765), in Relapsed or Refractory Mantle Cell Lymphoma (MCL): Durable Efficacy and Tolerability with Longer Follow-up

Michael Wang, M.D., Simon A. Rule, MD, Peter Martin, MD, Andre Goy, MD, Rebecca Auer, MD, Brad S. Kahl, M.D., Wojciech Jurczak, Ranjana H. Advani, MD, Jorge Enrique E Romaguera, MD, Jesse McGreivy, MD, Fong Clow, ScD, Michelle Stevens-Brogan, Lori Kunkel, MD, Kristie A. Blum, MD
Journal: Blood
Blood (2012) 120 (21): 904.
https://doi.org/10.1182/blood.V120.21.904.904
Published: 2012